TrovaGene
Why Robinhood?
You can watch TrovaGene and buy or sell other stocks, ETFs, and their options commission-free!About TROV
Cardiff Oncology, Inc. is an oncology therapeutics company, which engages in the development of drugs that target mitosis for the treatment of various types of cancer. The firm is focused on developing onvansertib, a first-in-class, third-generation Polo-like Kinase 1 (PLK1) inhibitor, in combination with standard-of-care chemotherapy and targeted therapeutics.
TROV Key Statistics
Stock Snapshot
With a market cap of 81.28M, TrovaGene(TROV) trades at $1.19. The stock has a price-to-earnings ratio of -2.93.
During the trading day, TrovaGene(TROV) stock saw an opening price of —, a peak of —, and a bottom of —.
Trading volume for TrovaGene(TROV) stock has reached 0, versus its average volume of 749.05K.
Over the past 52 weeks, TrovaGene(TROV) stock has traded between a high of $4.56 and a low of $1.48.
Over the past 52 weeks, TrovaGene(TROV) stock has traded between a high of $4.56 and a low of $1.48.
People also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.